Products

Galen Second Read
Ibex Medical Analytics
Oncology AI
Galen™ Second Read™ (now Ibex Prostate Detect in the US) is an AI-powered digital pathology solution by Ibex Medical Analytics that analyzes prostate core needle biopsies to detect potentially missed cancers, providing pathologists with alerts and heatmaps to enhance diagnostic accuracy and streamline workflows.

See all 1 product →

About Ibex Medical Analytics

Ibex Medical Analytics is a leading healthcare AI company that develops clinical-grade artificial intelligence solutions for cancer diagnostics. Their core product, the Galen™ platform, utilizes advanced machine learning and image analysis to analyze digitized pathology slides, assisting pathologists in detecting and grading cancer in biopsies and identifying other clinically important findings. This technology aims to improve diagnostic accuracy and efficiency, address rising cancer prevalence, increasing diagnostic complexity, and a global shortage of pathologists.

The Galen platform is designed to integrate into routine clinical practice, offering AI-powered workflows and decision support tools. It provides solutions for various cancer types, including breast, prostate, lung, and gastric cancers, for both H&E and IHC staining. Ibex’s solutions are deployed globally and have demonstrated success in detecting missed cancer cases, enhancing diagnostic quality, reducing turnaround times, and boosting productivity. The company also focuses on developing computational prognostic and predictive tests to enable enhanced patient stratification and personalized treatment selection, and is expanding into biopharma to support drug development from biomarker assessment and clinical trial optimization through regulatory clearance and clinical deployment.

Focus Areas

AI-powered cancer diagnostics digital pathology computational pathology medical imaging healthcare analytics computer vision biomarker scoring clinical decision support precision diagnostics

Business Intelligence

TechnologyCloud-native, AI-powered Galen™ platform utilizing deep learning algorithms for image analysis, with an open API for integration with digital pathology software, scanning platforms, and laboratory information systems.

What Physicians Need to Know

AI-Powered Cancer Diagnostics
Ibex Medical Analytics specializes in AI-powered cancer diagnostics, leveraging its Galen™ platform to analyze biopsy images for the detection, grading, and flagging of various cancers, including prostate, breast, and gastric cancer. Their solutions are designed to enhance diagnostic accuracy, implement real-time quality control, and reduce turnaround times.
Digital Pathology
Ibex is a leader in AI-enabled digital pathology, transforming traditional anatomic pathology by making AI easily accessible to pathologists. Their platform seamlessly integrates with third-party digital pathology software solutions, scanning platforms, and laboratory information systems (LIS).
Breast Cancer Diagnostics
Ibex offers a comprehensive breast solution, including automated H&E analysis and 'zero-click' IHC quantification for HER2, ER, PR, and Ki67. Their AI tools can identify HER2 ultralow expression, potentially increasing the number of patients eligible for targeted therapy.
Prostate Cancer Diagnostics
Ibex Prostate assists pathologists in detecting and grading prostate cancer and other clinically relevant findings in both core needle biopsies and transurethral resection of the prostate (TURP).
Gastric Cancer Diagnostics
The Ibex platform provides clinical-grade solutions for the accurate diagnosis of gastric biopsies.
Biomarker Discovery & Clinical Trial Efficiency
Ibex is expanding its biopharma business to support early translational research, biomarker development, and trial efficiency optimization. They partner with pharmaceutical organizations to develop AI-powered quantification and scoring solutions for complex IHC biomarkers.
Image Analysis, Machine Learning & Deep Learning
The Ibex platform leverages rigorous deep learning techniques and algorithms trained by a diverse team of senior pathologists using over 150,000 image annotations. It analyzes images from various digital pathology platforms and staining protocols, along with millions of pathology reports and medical records.
Quality Control & Workflow Optimization
Ibex solutions provide automated high-quality insights that enhance patient safety, increase physician confidence, and boost productivity. They act as a high-precision diagnostic aid and safety net to ensure no suspicious lesions are overlooked. The platform can lead to up to 40% increased productivity and improved diagnostic accuracy.
Key Differentiators
Ibex's key differentiators include an AI-first, clinician-designed platform built by pathologists for pathologists, offering unprecedented insights for cancer detection and workflow optimization. It is the most widely used AI in live pathology rollouts worldwide, with strong growth in patient cases and customers. The platform is clinically proven, with outstanding outcomes in rigorous worldwide clinical studies.
Technology Stack
The Ibex AI-powered diagnostic platform utilizes images from various digital pathology platforms and staining protocols, millions of pathology reports and medical records, and algorithms trained by expert pathologists using deep learning techniques. The system is designed for security, scalability, and global deployment, compatible with leading WSI scanners, DICOM-DP infrastructure, HL7/FHIR workflows, and structured outputs for regulated trial endpoints.
Physician Tip

For pathologists, Ibex Medical Analytics' solutions offer enhanced diagnostic quality, faster results, and greater confidence by providing an AI-powered 'safety net' that detects small foci or high-grade tumors that might otherwise be missed. The platform streamlines workflows, reduces workload, and automates quality control, allowing pathologists to focus their expertise on critical diagnostic tasks. The 'zero-click' IHC quantification and visualization tools, particularly in breast cancer diagnostics, can significantly aid in identifying subtle staining and calculating proliferation indexes, overcoming interobserver variability. For providers, Ibex offers better patient outcomes, higher productivity, more efficient workflows, and improved service quality.

Ibex's platform is designed for seamless integration with leading providers of Laboratory Information Systems (LIS), Image Management Systems (IMS), and Whole Slide Imaging (WSI) Scanners. They have strategic partnerships with companies like Philips and mTuitive to enhance AI-enabled pathology workflows and integrate AI findings into structured reporting. This interoperability ensures that AI insights are accessible from preferred image management systems and supports efficient end-to-end clinical workflows.

Products by Ibex Medical Analytics

1 product in the directory

Galen Second Read
Ibex Medical Analytics
Oncology AI
Galen™ Second Read™ (now Ibex Prostate Detect in the US) is an AI-powered digital pathology solution by Ibex Medical Analytics that analyzes prostate core needle biopsies to detect potentially missed cancers, providing pathologists with alerts and heatmaps to enhance diagnostic accuracy and streamline workflows.

Videos

News, demos, and interviews about Ibex Medical Analytics.

Loading videos...

Videos load interactively. If none appear, search YouTube for Ibex Medical Analytics →

View all on YouTube

No press coverage or publications on file yet. Know of some? Suggest an edit →

Frequently Asked Questions

Ibex Medical Analytics offers AI-powered cancer diagnostic solutions, primarily focusing on digital pathology. Their Galen™ platform currently supports detection and grading for prostate cancer, breast cancer, and gastric cancer, aiming to improve diagnostic accuracy and efficiency for pathologists.
Ibex's AI technology is designed to integrate seamlessly into existing digital pathology workflows, acting as an assistive tool for pathologists. It requires a digital pathology infrastructure, including whole slide scanners and a picture archiving and communication system (PACS), to process and analyze digitized tissue samples.
Clinical studies and real-world deployments have demonstrated that Ibex's AI significantly improves diagnostic accuracy, acts as a robust quality control mechanism, and helps reduce diagnostic errors in cancer detection. The system utilizes advanced image analysis, machine learning, and deep learning algorithms to provide reliable and consistent results.
Ibex's AI platform can contribute to biomarker discovery by identifying subtle patterns and features in tissue samples that may correlate with disease progression or treatment response. This capability can enhance clinical trial efficiency by streamlining patient stratification and accelerate CDx-ready evidence generation through more precise and quantitative analysis of pathology slides.
Ibex Medical Analytics typically offers flexible pricing models tailored to the size and needs of the healthcare institution, often based on usage or a subscription basis. They provide comprehensive technical support, including integration assistance, ongoing maintenance, and training programs for pathologists and lab staff to ensure effective utilization of their AI platform.
Ibex Medical Analytics has established partnerships with leading healthcare technology companies, digital pathology providers, and research institutions to further develop and expand the reach of its AI solutions. The company demonstrates strong stability, backed by significant investment and a clear vision to become a global leader in AI-powered cancer diagnostics, continuously innovating to improve patient care.

Investors

Who's funded Ibex Medical Analytics.

Related Companies

Spectrum Dynamics Medical is a pioneering medical device company focused on transforming nuclear medicine from analog to digital technology. They specialize in developing high-definition, solid-state based nuclear imaging technology, including digital SPECT (Single Photon Emission Computed Tomography) and SPECT/CT systems. Their products aim to meet the clinical needs and workflow demands of diagnostic imaging departments […]

Siemens Medical Solutions USA, Inc., operating as Siemens Healthineers USA, is a prominent medical technology company with a rich history spanning over 175 years, dedicated to pioneering breakthroughs in healthcare. As a subsidiary of the global Siemens Healthineers AG, the company offers a comprehensive portfolio that is central to clinical decision-making across the entire healthcare […]

Siemens Healthineers is a leading global medical technology company that pioneers breakthroughs in healthcare. The company focuses on medical technology and diagnostics, offering a wide range of products including imaging systems, laboratory diagnostics, and advanced therapies. Their innovations aim to improve patient outcomes and make healthcare more accessible and sustainable. Siemens Healthineers has a strong […]

Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]

PathologyAILab offers advanced digital cytology services, leveraging a multi-agent AI system for cervical cancer diagnosis. This innovative solution provides comprehensive image analysis to deliver precise and reliable diagnostic insights to healthcare professionals. The service aims to provide rapid results, typically within 2-4 hours, for urgent cases, enabling timely clinical decisions. The process involves submitting digital […]

Varian Medical Systems, now a Siemens Healthineers company, is a global leader in advanced radiation oncology solutions for comprehensive cancer treatment. The company develops and manufactures medical devices and software for treating cancer and other medical conditions using therapies such as radiotherapy, radiosurgery, proton therapy, and brachytherapy. Their product portfolio includes linear accelerators (LINACs), proton […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.